PepGuard vs DrugCard
A side-by-side comparison built from both listings. Blank cells mean the company has not given that detail; we never guess.
PepGuard compared with DrugCard
| Detail |
PepGuard |
DrugCard |
| What it does | AI-powered peptide safety analysis against published evidence
| AI-powered pharmacovigilance automation for global and local literature monitoring and regulatory intelligence
|
|---|
| Stage | Not given
| Established
|
|---|
| Founded | Not given
| 2019
|
|---|
| Based in | Not given
| EE
|
|---|
| Pricing model | Paid
| Not given
|
|---|
| Pricing | Starter: $15/mo (100 checks/month, 1 stack). Pro: $19/mo (125 checks/month, 3 stacks, stack interaction analysis, PDF export). Clinic: $25/mo (165 checks/month, 10 stacks, stack interaction analysis, PDF export, priority support). Weekly and monthly billing cycles available.
| Not given
|
|---|
| Key features | - AI-powered safety scoring weighted by study design and sample size
- Regulatory status lookup for US FDA approvals and investigational status
- Peptide stack builder with dosing calendar and adherence tracking
- Stack interaction analysis across multiple compounds
- PDF export of full reports
- Mobile app label scanning capability
- Real-time evidence retrieval from three primary sources
- Risk flag identification for specific peptides
| - Automated literature monitoring across 100+ languages
- Coverage of 151+ countries and 2300+ local medical journals
- OCR technology with 99% accuracy for scanned texts
- Regulatory intelligence tracking
- Adverse event database and case management
- AI Case Intake module for automated data extraction
- PSUR and PBRER automation
- Weekly and instant email notifications
- Signal detection capabilities
- Integration with safety database for auto-population
|
|---|
| What makes it different | - No vendor spin or cherry-picked studies in reports
- Evidence scored by research quality, not advertising budget
- Covers 29 peptide compounds with detailed analysis
- Results delivered in seconds with full source traceability
- No medical advice: pure research summarization tool
| - Covers 100+ languages and 2300+ local journals globally
- Achieves 50-70% time savings versus manual screening
- Discovers 3-5x more relevant hits than manual approaches
- Proprietary AI and OCR technology with 99% accuracy
- Quick onboarding and deployment within 2 business days
|
| Community votes | 0 | 0 |
| DR (Domain Rating by Ahrefs) | Not checked yet ● no change since last check | 44 ▲ +1 (up) since last check |
| Trust Flow (Majestic) | 0 | 12 |
| Citation Flow (Majestic) | 10 | 32 |
| Referring domains (Majestic) | 11 | 194 |
3 details filled in for both companies.
More alternatives to PepGuard More alternatives to DrugCard